1. Home
  2. PUSA vs BDTX Comparison

PUSA vs BDTX Comparison

Compare PUSA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aureus Greenway Holdings Inc. Common Stock

PUSA

Aureus Greenway Holdings Inc. Common Stock

N/A

Current Price

$1.54

Market Cap

101.2M

ML Signal

N/A

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

N/A

Current Price

$1.43

Market Cap

104.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PUSA
BDTX
Founded
2023
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
104.0M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
PUSA
BDTX
Price
$1.54
$1.43
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$6.25
★ $11.00
AVG Volume (30 Days)
753.2K
★ 856.2K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 130.71
EPS
★ N/A
N/A
Revenue
★ $2,964,377.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$301.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.27
$1.39
52 Week High
$4.45
$4.06

Technical Indicators

Market Signals
Indicator
PUSA
BDTX
Relative Strength Index (RSI) 36.68 37.50
Support Level N/A N/A
Resistance Level $3.95 $1.94
Average True Range (ATR) 0.17 0.15
MACD 0.05 -0.03
Stochastic Oscillator 46.15 8.77

Price Performance

Historical Comparison
PUSA
BDTX

About PUSA Aureus Greenway Holdings Inc. Common Stock

Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: